AADvac1 for Progressive Supranuclear Palsy

PR
Overseen ByPTP Recruitment and Retention (RER) Team
Age: 18+
Sex: Any
Trial Phase: Phase 2
Sponsor: Adam Boxer
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

The Progressive Supranuclear Palsy Clinical Trial Platform (PTP) is a multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of PSP.

Regimen A will evaluate the safety and efficacy of a single study drug, AADvac1, in participants with PSP.

Who Is on the Research Team?

IL

Irene Litvan, MD

Principal Investigator

University of California, San Diego

JR

Julio Rojas-Martinez, MD, PhD

Principal Investigator

University of California, San Francisco

AW

Anne-Marie Wills, MD

Principal Investigator

Massachusetts General Hospital

AB

Adam Boxer, MD, PhD

Principal Investigator

University of California, San Francisco

Are You a Good Fit for This Trial?

This trial is for people diagnosed with possible or probable Progressive Supranuclear Palsy (PSP) Richardson's Syndrome, who have had symptoms for 5 years or less. Participants must be able to walk at least 10 steps with minimal help, have good mental function, and live at home or in the community.

Inclusion Criteria

I live at home or in a community setting, including assisted living.
I have been diagnosed with possible or probable PSP Richardson's Syndrome.
My mental state score is 25 or higher.
See 4 more

What Are the Treatments Tested in This Trial?

Interventions

  • AADvac1

Trial Overview

The study is testing AADvac1, an experimental drug, compared to a placebo in people with PSP. The goal is to see if AADvac1 is safe and effective. Participants are randomly assigned to receive either the drug or a placebo.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Placebo Group

Group I: AADvac1Experimental Treatment1 Intervention
Group II: Matching PlaceboPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Adam Boxer

Lead Sponsor

Trials
2
Recruited
50+

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+

Alzheimer's Therapeutic Research Institute

Collaborator

Trials
18
Recruited
58,400+

University of Southern California

Collaborator

Trials
956
Recruited
1,609,000+

Massachusetts General Hospital

Collaborator

Trials
3,066
Recruited
13,430,000+

Alzheimer's Clinical Trials Consortium

Collaborator

Trials
5
Recruited
2,800+

University of California, San Diego

Collaborator

Trials
1,215
Recruited
1,593,000+

Axon Neuroscience SE

Industry Sponsor

Trials
4
Recruited
300+